Complications following percutaneous liver biopsy: A multicentre retrospective study on 68 276 biopsies

doi:10.1016/S0168-8278(86)80075-7

Journal of Hepatology

Volume 2, Issue 2, 1986, Pages 165-173

https://doi.org/10.1016/S0168-8278(86)80075-7 Get rights and content

Summary

This paper reviews the complications that arose after 68 276 percutaneous liver biopsies performed from 1973 to 1983. The complications are analyzed in relation to the underlying liver disease and to the type of needle used. Death was infrequent (9/100 000); it was always due to haemoperitoneum and occurred only in patients with malignant diseases or cirrhosis. Complications were less frequent in AVH (44/100 000) than in other liver diseases (from 125 to 278/100 000). Death, serious haemorrhagic complications, pneumothorax and biliary peritonitis were more frequent after biopsy with the Trucut needle than after biopsy with Menghini's needle (3/1000 against 1/1000).

Sixty-one percent of complications were discovered within two hours of biopsy and 96% within one day. The data indicate a post biopsy observation period of at least 24 hours. The day-case procedure should be reserved for patients not presenting liver tumour or cirrhosis.

References (30)

RainesD.R. et al.
Intrahepatic hematoma: A complication of percutaneous liver biopsy — A report on the incidence of post-biopsy scan defects
Gastroenterology
(1974)
ConnH.
Intrahepatic hematoma after liver biopsy
Gastroenterology
(1974)
BallT.J. et al.
Haemobilia following percutaneous liver biopsy
Gastroenterology
(1975)
LeeS.P. et al.
Traumatic haemobilia — A complication of percutaneous liver biopsy
Gastroenterology
(1977)
OkudaK. et al.
Frequency of intrahepatic arteriovenous fistula as a sequela to percutaneous needle puncture of the liver
Gastroenterology
(1978)
PerraultJ. et al.
Liver biopsy — Complications in 1000 inpatients and outpatients
Gastroenterology
(1978)
KnauerC.M.
Percutaneous biopsy of the liver as a procedure for out-patients
Gastroenterology
(1978)
MenghiniG.
One second needle liver biopsy of the liver
Gastroenterology
(1958)
KlatskinG. et al.
Complications encountered in 352 liver biopsies
Yale F. Biol. Med.
(1950)
GallisonD.T. et al.
Bile peritonitis complicating needle biopsy of liver
N. Engl. J. Med.
(1950)

OzonoffM.B.

Roentgenologic demonstration of intrahepatic hematoma following liver biopsy

Amer. J. Dig. Dis.

(1962)

ViranuvattiV. et al.

Needle liver biopsy with particular reference to complications

Amer. J. Gastroenterol.

(1964)

PregerL.

Hepatic arteriovenous fistula after percutaneous liver biopsy

Amer. J. Roentgenol. Radium Ther. Nucl. Med.

(1967)

CoxE.F.

Hemobilia following percutaneous needle biopsy of the liver

Arch. Surg.

(1967)

JohnsonR.A. et al.

Intrahepatic hematoma following liver biopsy by the Menghini technic

Amer. J. Gastroenterol.

(1968)

Cited by (1077)

Battle of the biopsies: Role of tissue and liquid biopsy in hepatocellular carcinoma
2024, Journal of Hepatology
The diagnosis and management of hepatocellular carcinoma (HCC) have improved significantly in recent years. With the introduction of immunotherapy-based combination therapy, there has been a notable expansion in treatment options for patients with unresectable HCC. Simultaneously, innovative molecular tests for early detection and management of HCC are emerging. This progress prompts a key question: as liquid biopsy techniques rise in prominence, will they replace traditional tissue biopsies, or will both techniques remain relevant? Given the ongoing challenges of early HCC detection, including issues with ultrasound sensitivity, accessibility, and patient adherence to surveillance, the evolution of diagnostic techniques is more relevant than ever. Furthermore, the accurate stratification of HCC is limited by the absence of reliable biomarkers which can predict response to therapies. While the advantages of molecular diagnostics are evident, their potential has not yet been fully harnessed, largely because tissue biopsies are not routinely performed for HCC. Liquid biopsies, analysing components such as circulating tumour cells, DNA, and extracellular vesicles, provide a promising alternative, though they are still associated with challenges related to sensitivity, cost, and accessibility. The early results from multi-analyte liquid biopsy panels are promising and suggest they could play a transformative role in HCC detection and management; however, comprehensive clinical validation is still ongoing. In this review, we explore the challenges and potential of both tissue and liquid biopsy, highlighting that these diagnostic methods, while distinct in their approaches, are set to jointly reshape the future of HCC management.
Prospective evaluation of liver shearwave elastography measurements with 3 different technologies and same day liver biopsy in patients with chronic liver disease
2024, Digestive and Liver Disease
Most ultrasound-based methods for assessing liver fibrosis still need further validation with liver biopsy used as gold standard to assess their accuracy.
To assess accuracy of three shear wave elastography (SWE) methods: 1) Philips Elast Point Quantification (ElastPQ^TM), 2) Siemens Virtual Touch^TM Quantification (VTQ) acoustic radiation force impulse (ARFI), and 3) transient elastography (TE) measured by Echosens Fibroscan^TM.
160 patients underwent liver stiffness measurements (LSM) with three SWE methods immediately prior to liver biopsy.
The number of LSM required for reliable studies could be reduced to 6 for ElastPQ and to 7 for VTQ from standard recommendations of 10. Significant fibrosis and interquartile range/median (IQR/M)> 30 were independent predictors for lower reliability for detection of liver fibrosis. Ordinal logistic regression corrected for age showed that there was a significant interaction between steatosis (p = 0.008) and lobular inflammation (p = 0.04) and VTQ (ARFI) and between lobular inflammation and TE (p = 0.006).
We showed variations in SWE measurements using different ARFI technologies. TE and ElastPQ achieved good diagnostic performance, whereas VTQ showed lower diagnostic accuracy. The number of measurements required for reliable studies can be reduced to 6 for ElastPQ and to 7 for VTQ, which have important clinical implications.
Niche preclinical and clinical applications of photoacoustic imaging with endogenous contrast
2023, Photoacoustics
In the past decade, photoacoustic (PA) imaging has attracted a great deal of popularity as an emergent diagnostic technology owing to its successful demonstration in both preclinical and clinical arenas by various academic and industrial research groups. Such steady growth of PA imaging can mainly be attributed to its salient features, including being non-ionizing, cost-effective, easily deployable, and having sufficient axial, lateral, and temporal resolutions for resolving various tissue characteristics and assessing the therapeutic efficacy. In addition, PA imaging can easily be integrated with the ultrasound imaging systems, the combination of which confers the ability to co-register and cross-reference various features in the structural, functional, and molecular imaging regimes. PA imaging relies on either an endogenous source of contrast (e.g., hemoglobin) or those of an exogenous nature such as nano-sized tunable optical absorbers or dyes that may boost imaging contrast beyond that provided by the endogenous sources. In this review, we discuss the applications of PA imaging with endogenous contrast as they pertain to clinically relevant niches, including tissue characterization, cancer diagnostics/therapies (termed as theranostics), cardiovascular applications, and surgical applications. We believe that PA imaging’s role as a facile indicator of several disease-relevant states will continue to expand and evolve as it is adopted by an increasing number of research laboratories and clinics worldwide.
Quantifying the Impact of Imaging Through Body Walls on Shear Wave Elasticity Measurements
2023, Ultrasound in Medicine and Biology
In the context of ultrasonic hepatic shear wave elasticity imaging (SWEI), measurement success has been determined to increase when using elevated acoustic output pressures. As SWEI sequences consist of two distinct operations (pushing and tracking), acquisition failures could be attributed to (i) insufficient acoustic radiation force generation resulting in inadequate shear wave amplitude and/or (ii) distorted ultrasonic tissue motion tracking. In the study described here, an opposing window experimental setup that isolated body wall effects separately between the push and track SWEI operations was implemented. A commonly employed commercial track configuration was used, harmonic multiple-track-location SWEI. The effects of imaging through body walls on the pushing and tracking operations of SWEI as a function of mechanical index (MI), spanning 5 different push beam MIs and 10 track beam MIs, were independently assessed using porcine body walls. Shear wave speed yield was found to increase with both increasing push and track MI. Although not consistent across all samples, measurements in a subset of body walls were found to be signal limited during tracking and to increase yield by up to 35% when increasing electronic signal-to-noise ratio by increasing harmonic track transmit pressure.
Comparative study of ultrasound attenuation analysis and controlled attenuation parameter in the diagnosis and grading of liver steatosis in non-alcoholic fatty liver disease patients
2024, BMC Gastroenterology
Point Shear Wave Elastography Detected Liver Stiffness Increased in Pediatric Patient With Thalassemia Major
2024, Ultrasound Quarterly

View all citing articles on Scopus

^*: This investigation was supported by C.N.R., Rome ‘Progetto Finalizzato Prevenzione delle Malattie da Infezione’, Grant No. 84.01865.52. The study was performed under the sponsorship of the Italian Association for the Study of the Liver (AISF).

View full text

Research PaperComplications following percutaneous liver biopsy: A multicentre retrospective study on 68 276 biopsies*

Summary

Gastroenterology

Gastroenterology

Gastroenterology

Gastroenterology

Gastroenterology

Gastroenterology

Gastroenterology

Gastroenterology

Complications encountered in 352 liver biopsies

Yale F. Biol. Med.

Bile peritonitis complicating needle biopsy of liver

N. Engl. J. Med.

Roentgenologic demonstration of intrahepatic hematoma following liver biopsy

Amer. J. Dig. Dis.

Needle liver biopsy with particular reference to complications

Amer. J. Gastroenterol.

Hepatic arteriovenous fistula after percutaneous liver biopsy

Amer. J. Roentgenol. Radium Ther. Nucl. Med.

Hemobilia following percutaneous needle biopsy of the liver

Arch. Surg.

Intrahepatic hematoma following liver biopsy by the Menghini technic

Amer. J. Gastroenterol.

Research Paper
Complications following percutaneous liver biopsy: A multicentre retrospective study on 68 276 biopsies*